85 related articles for article (PubMed ID: 21039037)
21. Mutations of p53 gene in breast cancer in the Egyptian province of Dakahliya.
El-Ghannam DM; Arafa M; Badrawy T
J Oncol Pharm Pract; 2011 Jun; 17(2):119-24. PubMed ID: 20015931
[TBL] [Abstract][Full Text] [Related]
22. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
23. Caveolin-1 and breast cancer: a new clinical perspective.
Mercier I; Lisanti MP
Adv Exp Med Biol; 2012; 729():83-94. PubMed ID: 22411315
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent.
Ayub SG; Rasool S; Ayub T; Khan SN; Wani KA; Andrabi KI
Mol Med Rep; 2014 Feb; 9(2):749-53. PubMed ID: 24337145
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
Kechagioglou P; Papi RM; Provatopoulou X; Kalogera E; Papadimitriou E; Grigoropoulos P; Nonni A; Zografos G; Kyriakidis DA; Gounaris A
Anticancer Res; 2014 Mar; 34(3):1387-400. PubMed ID: 24596386
[TBL] [Abstract][Full Text] [Related]
26. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
27. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
Inayat U; Kayani MA; Faryal R
Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
[TBL] [Abstract][Full Text] [Related]
28. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
Chen FM; Hou MF; Chang MY; Wang JY; Hsieh JS; Ou-Yang F; Huang TJ; Lin SR
Cancer Lett; 2005 Apr; 220(2):177-84. PubMed ID: 15766593
[TBL] [Abstract][Full Text] [Related]
29. TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics.
Simão TA; Ribeiro FS; Amorim LM; Albano RM; Andrada-Serpa MJ; Cardoso LE; Mendonça GA; de Moura-Gallo CV
Int J Cancer; 2002 Sep; 101(1):69-73. PubMed ID: 12209590
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
32. Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
Canbay E; Degerli N; Gulluoglu BM; Kaya H; Sen M; Bardakci F
Curr Med Res Opin; 2004 Apr; 20(4):533-40. PubMed ID: 15119991
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
34. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers.
Chan TF; Su TH; Yeh KT; Chang JY; Lin TH; Chen JC; Yuang SS; Chang JG
Int J Oncol; 2003 Sep; 23(3):599-604. PubMed ID: 12888893
[TBL] [Abstract][Full Text] [Related]
35. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma.
Chen HL; Fan LF; Gao J; Ouyang JP; Zhang YX
Oncol Rep; 2011 Feb; 25(2):359-66. PubMed ID: 21165568
[TBL] [Abstract][Full Text] [Related]
36. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 gene-related hereditary susceptibility to breast and ovarian cancer in Latvia.
Tihomirova L; Vaivade I; Fokina O; Peculis R; Mandrika I; Sinicka O; Stengrevics A; Krilova A; Keire G; Petrevics J; Eglitis J; Timofejevs M; Leja M
Adv Med Sci; 2014 Mar; 59(1):114-9. PubMed ID: 24797986
[TBL] [Abstract][Full Text] [Related]
38. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
40. Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families.
Montagna M; Santacatterina M; Corneo B; Menin C; Serova O; Lenoir GM; Chieco-Bianchi L; D'Andrea E
Cancer Res; 1996 Dec; 56(23):5466-9. PubMed ID: 8968102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
